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Background: Optimal breastfeeding promotes child health and survival globally. Pro-breastfeeding HIV 
infant feeding policy changes in 2010, and the roll-out of universal maternal anti-retroviral therapy 
(ART) since 2013, have created an opportunity for re-establishment of breastfeeding among HIV-
exposed infants in resource-limited settings. Yet data are limited on breastfeeding practices under 
these policies. This study aimed to evaluate breastfeeding practices and predictors of breastfeeding 
cessation among women living with HIV (WLHIV) receiving universal ART, and a comparator group of 
HIV-negative (HIV-) women in Cape Town, South Africa.  
 
Methodology: This secondary data analysis used deidentified data from two parallel, prospective 
cohort studies conducted at the Gugulethu Midwife and Obstetric Unit between 2013 and 2017; the 
unit is certified as Baby-Friendly. Utilizing the same research staff, measurement tools and procedures, 
the studies followed pregnant women (HIV-; and WLHIV initiating universal ART) through delivery. HIV-
exposed infants received nevirapine and co-trimoxazole prophylaxis. At the early neonatal visit (± 7 
days), breastfeeding mother-infant pairs were eligible to continue follow-up (visits at 6 weeks; 3, 6, 9, 
12 months). At each study visit, trained field workers administered 24-hour recall questionnaires to 
assess infant feeding and asked about changes in feeding practices since the preceding visit. Exclusive 
breastfeeding (EBF) was defined as feeding infants no other food or drink other than breastmilk, except 
for medicines, vitamins and minerals. Breast feeding (BF) was censored at last visit with reported BF. 
We used Cox proportional hazards regression to assess factors associated with cessation of exclusive 
and all breastfeeding among HIV-negative children of both groups of women (HIV-exposed uninfected, 
HEU and HIV-unexposed, HU children), expressed as crude (HR) or adjusted hazard ratios (aHR).  
 
Results: Overall, 872 breastfeeding mother-infant pairs (HEU, n=461; HU, n=411) contributed 925 
person-years of follow-up. All WLHIV initiated ART in pregnancy (at ART initiation, median HIV viral 
load 3.97 log10 copies/mL; median CD4 cell count, 354 cells/uL); 352/461 (76%) of WLHIV had viral 
load <50 copies/mL at the time of delivery. Median (inter-quartile range, IQR) gestation at birth was 
39 (38-40) weeks, and birthweight, 3180 (2820-3460) grams; 424 (49%) of infants were boys. Early 
initiation of breastfeeding (EIBF, < 1 hour; overall, 788/867, 91%) was more common among HU than 
HEU infants (95% vs 87%, p<0.0001). Among infants who ever received EBF (754/872, 86%), median 
EBF duration was 1.4 (0.2-3.1) months. HEU vs HU infants were more likely to ever EBF (91% vs 81%, 
p<0.0001), with longer durations of EBF (median 1.5 vs 1.4 months, p=0.01; HR for EBF cessation, 0.78 
[95% CI 0.67-0.9]). The overall median duration of any breastfeeding was 6.0 (IQR 1.5-12.0) months, 
with earlier cessation among HEU (median 3.9 months) than HU infants (median 9.0 months); HR for 
BF cessation 1.87 (95% CI 1.56-2.24). Lactation issues (for example cracked nipples or engorgement) 
were common in the first 6 weeks postpartum (reported by 143 of 872, 16%), with greater risk among 
WLHIV than HIV- women (20% vs 12%, p=0.003). Lactation problems (vs none reported) were 
associated with increased relative hazard for EBF cessation among both HEU (HR 1.48, 95% CI 1.13-
1.96) and HU infants (HR 1.63, 95% CI 1.17-2.26); and for BF cessation among HEU infants (HR 2.45, 
95% CI 1.85-3.24). Study limitations include reliance on maternal recall, and inability to assess exact 
date of breastfeeding cessation.  
  
 
Conclusion: Breastfeeding practices remain poor among both WLHIV and HIV- women, despite pro-
breastfeeding HIV policy changes. An alarmingly high proportion of WLHIV reported lactation problems 
including cracked nipples. These data highlight an urgent need for lactation support among peri-urban 
women in our setting, especially those living with HIV, both to improve overall breastfeeding practices 






Part A: The study protocol was submitted for departmental and ethical approval and contains 
the background and methodology for this Masters in Public Health mini-dissertation. 
 
Part B: The journal-ready manuscript is presented according to the author guidelines for the 
Journal of Maternal and Child Nutrition. 
 
Part C: The appendices include all additional documentation necessary for the presentation 
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Breastfeeding and HIV 
 
Globally, exclusive breastfeeding is regarded as the optimal form of nutrition for infants during 
the first five to six months of life, where after breastfeeding should ideally be continued 
through the first 2 years of age alongside nutritionally sufficient complementary feeding 
practices. (1-8) Optimal breastfeeding practices have short and long-term health benefits, for 
both infant and mother. (8) Child health benefits include improved survival, protection against 
common childhood infections, increased intelligence levels as well as decreased risks of later-
life non-communicable diseases including obesity and diabetes. (9)   
Although breastfeeding benefits extend to both HIV-infected and -uninfected children, 
postnatal transmission of HIV may occur via breastfeeding, especially in the context of mixed 
feeding (provision of both infant formula and breastmilk in the first 6 months of life). (10) Prior 
to the availability of triple agent antiretroviral therapy (ART), breastfeeding was often avoided 
by HIV-infected mothers to reduce the risk of vertical transmission. (10,11) In this context, the 
absence of breastfeeding in high infectious burden settings resulted in high rates of death and 
infectious morbidity among HIV-exposed infants. (6,7)   However, in the context of HIV viral 
suppression on ART, HIV-infected women can breastfeed safely, with minimal risk of 
transmission. (12) Since 2010, the World Health Organization has recommended 
breastfeeding for all HIV-exposed children living in areas with high infectious disease burdens, 
provided mothers are virally suppressed on ART. (7,13) This recommendation is also reflected 
in recent changes to the stance of the South African health sector, whereby in 2011, policies 
were changed to promote and support breastfeeding as the default feeding method for 
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infants exposed to HIV. (6,11) However, policy changes alone may be insufficient to address 
the previously reported poor breastfeeding rates of both HIV-infected and HIV-uninfected 
women in South Africa. (14)  
 
Infant and young child feeding practices 
 
Optimal feeding practices constitute continued breastfeeding up to the age of two years, with 
the timely introduction of safe, adequate and appropriate complementary foods. (4,5,7,15,16)  
Optimal feeding practices among infants and young children (0-24months), in their so-called 
critical window of opportunity (15), are crucial for good developmental, health and survival 
outcomes. (4,5,7,15,16) Not only is it the time in their life in which they are most vulnerable 
to acute respiratory tract infections and diarrhoeal disease, but at the same time, they are 
experiencing rapid growth and development. (5) Nutritional deficiencies and sub-optimal 
feeding practices during this period in life potentially leads to stunting, increased risk of 
obesity, compromised cognitive development, impaired educational performance and 
ultimately lower economic productivity. (4,15,16)  
The importance of optimal infant feeding practices is highlighted by the high infant and young 
child mortality rates that are prevalent in South Africa. (7)  Here, mortality rates among infants 
and young children are commonly attributable to undernutrition as well as pneumonia and 
diarrhoea. (7,13) For these reasons, improvement of the previously reported poor infant 






Policy changes: breastfeeding and HIV 
 
To date, optimal breastfeeding practices in the context of postnatal Prevention of Mother to 
Child Transmission (PMTCT), have been hampered by confusion regarding optimal infant 
feeding practices. (17) This confusion was largely driven by rapidly changing sets of the World 
Health Organisation (WHO) published feeding guidelines in the context of HIV over time. (18) 
Between 2001 and 2011, these guidelines called for the avoidance of breastfeeding and for 
substitution with breastmilk substitutes, in an era when antiretroviral therapy was not widely 
available in Southern Africa. In this period in South Africa, free infant formula was distributed 
to most HIV-exposed infants up to the age of 6 months. (17,19) This promotion of the 
avoidance of breastfeeding in context of HIV was driven by concerns of HIV transmission via 
breastfeeding. However, several pivotal studies demonstrated markedly reduced risks of 
breastfeeding-associated HIV transmission in the context of maternal and/or infant use of 
antiretroviral agent. (20-22) Consequently, WHO infant feeding policies were changed in 2010; 
in turn, breastfeeding was subsequently promoted as the infant feeding practice of choice in 
the context of PMTCT in South Africa. (17,19) Contemporaneously, the WHO incorporated 
antiretroviral-based approaches to minimize breastfeeding related transmission. In 2013, 
South Africa adopted the so-called “Option B/B+” PMTCT policy, which requires all pregnant 
and breastfeeding HIV-infected women to receive triple agent antiretroviral therapy (ART) – 
in Option B+, the ART is continued lifelong. Option B+ PMTCT policies were introduced in the 
Western Cape in 2014; ART guidelines were subsequently updated to a “test-and-treat” policy 
for all people living with HIV. (23) Unfortunately, these rapidly changing policies and guidelines 
created confusion among feeding counsellors, while also creating a loss of confidence and 
trust in breastfeeding by mothers in general, as well as in healthcare providers and feeding 
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counsellors. Subsequently, this translated into confusing breastfeeding advice and support 
provided to mothers in PMTCT, and in turn, poor progression in the aim to improve actual 
feeding practices. (18,24) Indeed, data from soon after the implementation of the 2010 
feeding policy changes indicated that breastfeeding rates continued to be poor (14). Without 
actual improvements in breastfeeding rates, the optimum child health benefits of Option B+ 




Optimal breastfeeding practices are critical to child health. After a decade of vacillating 
guidelines and poor infant feeding practices, recent changes in HIV-related feeding and 
treatment guidelines have the potential to improve infant health and survival in South Africa. 
However, data are needed to assess the success of updated infant guideline implementation, 
and to identify potentially modifiable factors that continue to limit this potential success. To 
optimize successful implementation of these guidelines, a better understanding is required of 
the obstacles and facilitators of best feeding practices among both HIV-infected and HIV-
uninfected women, under current breastfeeding promotion and ART policies. 
 
2. Importance & Benefits of the proposed Study 
 
The results obtained from this study will contribute to a better understanding of obstacles and 
facilitators of optimal breastfeeding practices among HIV-infected and uninfected mothers in 
the Western Cape Province, South Africa, in the light of current ART and breastfeeding 
policies. In turn, a better understanding of these factors will enable improved support offered 
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to women in this setting. The results of this study will be published in the public domain and 
shared with local provincial groups, with the eventual aim of improving breastfeeding 
practices of infants in this, and similar peri-urban settings through science and advocacy. 
 
3. Research Question, Objective & Aims 
 
What are the breastfeeding practices, and predictors of early breastfeeding cessation, 
among HIV- infected and HIV-uninfected mothers and their infants in a peri-urban South 




The main objective of this study is to describe and compare breastfeeding practices and 
predictors of early breastfeeding cessation of HIV-infected and HIV-uninfected mothers and 
their infants at the Gugulethu Midwife and Obstetric Unit (MOU), during the first 3 years 




1. To describe breastfeeding practices using three related measures: 
a. WHO core indictors for breastfeeding in the first year of life, specifically: 




▪ Proportion of children exclusively breastfed until 6 months of age 
▪ Proportion of children who were still breastfeeding at age of 12 months 
b. Duration of any breastfeeding 
c. Age at introduction to complementary feeding 
2. To identify potential risk and facilitation factors that influence breastfeeding practices, 
including investigation of the effects of 
a. Lactation problems 
b. Maternal factors such as education, psychosocial and behavioural challenges  
c. Infant factors such as preterm birth 




While Aims #1 and #2 are hypothesis-generating, the following hypotheses underly Aim #3: 
HIV-infected women have less optimal breastfeeding practices, and more risk factors for early 
breastfeeding cessation, than HIV-uninfected women, specifically 
▪ HIV-infected women have shorter durations of breastfeeding than HIV-
uninfected women 
▪ HIV-infected women introduce complementary feeds at an earlier age than HIV-
uninfected women 
▪ HIV-infected women face more challenges to successful breastfeeding, with a 




5. Methodology  
 
5.1. Study Design 
 
The primary researcher proposes to address these objectives, based on secondary data 
obtained from two parent studies, which have been approved by the UCT HREC committees 
previously; MCH-ART (UCT HREC reference 451/2012, Appendix A) and HU2 (UCT HREC 
reference 567/2014, Appendix B).  
 Both the “Maternal and Child Health Anti-Retroviral Therapy (MCH-ART) and the “HIV-
unexposed uninfected (HU2) mother and infant” study are prospective cohort studies, 
examining amongst others health outcomes of HIV-exposed (MCH-ART) and unexposed (HU2) 
infants.  Data collection commenced in March 2013 and September 2014 respectively.  Both 
studies aimed to follow up for at least 12 months. The MCH-ART cohort is a multi-phase study, 
which recruited pregnant, HIV infected women sequentially at their first antenatal booking 
visit. Similarly, HU2 recruited participants sequentially at their first antenatal booking visit, 
however it recruited pregnant HIV-uninfected women seeking antenatal care. 
Phase 1 of MCH-ART enrolled HIV-infected, pregnant women attending their first antenatal 
visit at the Gugulethu MOU; for Phase 2, women from phase 1, eligible for ART initiation were 
followed as part of an observational cohort, while Phase 3 constituted a randomized trial of 
different methods of ART delivery to these postpartum women.  In HU2, pregnant, HIV-
uninfected women attending their first antenatal visit at the Gugulethu MOU were enrolled 
and followed in an observational cohort antenatally and then postnatally.  
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Data for this research will be derived from both baseline and longitudinal questionnaires 
regarding maternal demographics, infant feeding, psychosocial-behavioural factors and socio-
economic status.   
 
5.2. Study Setting 
 
Data for this secondary data analysis is obtained from the above-mentioned parent studies, 
set at the Gugulethu MOU on the premises of the Gugulethu Primary Healthcare Centre, which 
serves a population of roughly 350 000. It is located in Gugulethu, a low-income peri-urban 
township located in the Klipfontein sub-district of Cape Town, characterised by a high 
antenatal prevalence of HIV, close to 30%. (25) The Gugulethu MOU is a certified “baby-
friendly” hospital, in terms of the Baby Friendly Hospital initiative. Breastfeeding support 
counsellors are available on the premises. (26) 
 
5.3. Study Population & Sampling  
 
Study population 
The participants for this study, will be drawn from the MCH-ART (Phase 2 & 3) as well as the 
HU2 cohort studies.  The study populations for both cohorts were recruited from the 
Gugulethu MOU and followed up with their infants until these were at least 12 months old, 
and all had initiated breastfeeding after delivery. For the current analyses, children who were 
eligible for longitudinal follow-up will be included, except those who acquired HIV in the 
postnatal period. That is, the current analysis will be restricted to HIV-negative infants who 
9 
 
initiated breastfeeding after birth and were followed in the postnatal aspects of the parent 
studies, to obtain longitudinal measures.  
Please see Appendix C for a detailed list of inclusion and exclusion criteria for the parent 
studies. 
 
Sample size calculations 
 
This secondary data analysis will use the available sample of mothers and children; sample 
size for the main study was based on the primary objectives for the main studies. All results 
will be presented with 95% confidence intervals to indicate achieved precision of the 
estimates; no post-hoc power calculations will be done. 
 
5.4. Data collection 
 
All data used for the purposes of this study were collected at a study research site on the 
premises of the Gugulethu MOU for both parent studies.  Study procedures and measures 




Data was obtained through Clinical record forms (CRFs), and questions were administered by 
trained interviewers in private rooms.  CRFs were translated from English into isiXhosa and 
subsequently back-translated by isiXhosa speaking staff members, with validation 
certification. For the purposes of this study, data derived from the “Infant feeding 
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intentions/practices” questionnaire (Appendix D) will be used to evaluate breastfeeding 
practices.  This questionnaire was administered in both parent cohorts during post-natal 
follow up visits at approximately <7 days, 6 weeks, 3,6,9 and 12 months.  Additionally, selected 
data derived from the “Maternal Demographics & Medical History Questionnaire” will be 
used, as well as the Edinburgh Postnatal Depression Scale (EPDS) (Appendix L), the Kessler-10 
(Appendix M), the Trauma/Abuse Assessment (Appendix N) and the Alcohol Use Disorders 
Identification Test- (AUDIT) (Appendix O).  The HU2 questionnaire (Appendix E) was an 
appropriately shortened version (so as not to enquire about HIV/ART related information) of 




Exploratory analysis will evaluate breastfeeding and weaning practices, as well as reported 
reasons for breastfeeding cessation among both HIV-infected and HIV-uninfected mothers.  
These will be evaluated in the light of (including but not limited to) work commitments, 
lactation-problems, pressure from family or health care workers and maternal mental health.   
Please see Appendix G for a Directed Acyclic Graph. 
 
6. Statistical Analysis & Data management 
 
Data capturing, safety and monitoring 
 
All data have been captured as part of the conduction of the parent cohort studies, at the 
Gugulethu Research Site of the University of Cape Town, School of Public Health and Family 
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Medicine.  As per study protocols, all participant data was kept anonymous with no personal 
identifiers attached to participant files and with only systematically assigned identification 
numbers.  Database files are stored on password protected external hard drives which in turn 




This study involves secondary data analysis of data derived from the two parent prospective 
cohort studies, as discussed above. 
All data analysis will be performed by the primary researcher and analysis will be conducted 
using Stata, Version 14.0.   
 
Proposed statistical tests include but are not limited to: 
 
Table 1:  Proposed Statistical tests 
 Data type Statistical approach and/or test 
Descriptive & summary 
statistics 
Categorical Data Frequencies, percentages & proportions  
Bar graphs, mosaic plots 
Numerical Data Mean (Standard Deviation), compared using t-tests, or 
Median (Inter Quartile Range) * 
Box-and-whiskers plots, scatterplots 
Correlation coefficients, 
comparisons & basic tests  
Categorical Data ANOVA, Chi-Square or Fishers exact test* 
Numerical Data Wilcoxon sum rank or T-tests* 
Associations & Hypothesis 
testing 
Generalized Linear Models (link function dependent on distribution of outcome) will be 
used to assess factors associated with early feeding practices  
Survival analysis and Cox proportional hazards regression models will be used to assess 






7. Ethical & Legal considerations 
 
Both parent studies obtained ethical approval from the University of Cape Town Faculty of 
Health Services Research Ethics committee (UCT-HREC) and (MCH-ART specifically) from the 
Columbia University Medical Centre Institutional Review Board (CUMC-IRB).  This includes 
study protocols, informed consent forms and data collection tools.  Both parent studies 
proceeded with full ethical approval. 
This sub-study will commence only with the ethical approval from UCT-REC and will only 
include data from participants who have provided informed consent. 
Since this is a secondary data analysis of previously collected, anonymous data, it is 
anticipated to pose minimal risks to the participants.  No direct benefit will be incurred by 
participants for taking part in this study, however information derived may feed into further 
research and infant feeding education campaigns and projects. 
 
Informed consent  
 
For the purposes of this sub-study using secondary data analysis, no further consent is needed.  
Participants were consented through the MCH-ART and HU2 consent process, by a trained 
interviewer, in isiXhosa making use of standardized consent forms (Appendices H-K).  
Participation was entirely voluntary.  During the consent process, participants were informed 






Privacy and confidentiality 
 
Data privacy, anonymity and confidentiality will be ensured always, as discussed in “Data 
capturing, safety and monitoring” above.  For the purposes of this research study, no contact 
will be established with study participants. 
 
8. Logistics & Time schedule 
 
Table 2:  Gannt Chart of Actions and Timelines 
Year 2013 - 2017 2018 2019 2020 






Actions       
Data Collection       
Protocol Finalization       
UCT-REC Submission & 
Feedback 
      
Data Processing       
Data Analysis       
Thesis write up       




The primary researcher will receive no funding for the analysis of this data.  No funding is 









10. List of Abbreviations 
 





HIV human immunodeficiency virus 
HU2 HIV-unexposed uninfected mother and infant cohort study 
MCH-ART maternal and child health antiretroviral therapy cohort study 
MOU midwife and obstetrics unit 
PMTCT prevention of mother-to-child transmission   
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Background:  Optimal breastfeeding (BF) promotes child survival. Little is known about BF 
practices among women living with HIV (WLHIV) in the era of universal maternal antiretroviral 
therapy (ART). We investigated BF practices and predictors of cessation among WLHIV 
receiving universal ART in peri-urban Cape Town, South Africa. 
Methodology:  Two parallel, prospective cohort studies (2013-2017, primary care setting) 
enrolled breastfeeding mother-infant pairs at ±7days postpartum. We evaluated BF practices 
(24-hour recall, at 6 weeks; 3, 6, 9, 12 months) among WLHIV (HIV-exposed uninfected, HEU 
infants) versus HIV-negative women (HIV-unexposed, HU infants).  We used Cox proportional 
hazards regression to compare predictors of BF cessation.  
Results:  Overall, 872 mother-infant pairs (n=461 HEU; n=411 HU) breastfed for a median 
(interquartile range, IQR) of 6.0 (IQR 1.5-12.0) months; median exclusive BF (EBF) duration 
was 1.4 (0.1-3.0) months. Early initiation of breastfeeding (<1 hour from birth) was more 
common among HU vs HEU infants (95% vs 87%, p<000.1). A larger proportion of HEU vs HU 
infants ever EBF (91% vs 81%, p<000.1), or were still EBF at 6 months (54% vs 15%, p<000.1). 
BF cessation occurred earlier among HEU than HU infants, (BF at 12 months, 39% vs 50%; 
p=0.01). Lactation problems were common and predicted cessation of EBF vs. no lactation 
problems, (HR 1.46, 95% Confidence Interval [CI] 1.17; 1.81) and BF (HR 1.98, 95% CI 1.56; 
2.51).  
Conclusion: Breastfeeding practices remain poor among WLHIV and HIV-negative women, 
despite pro-breastfeeding HIV policies. This data highlights an urgent need for improved 
lactation support among women in this setting.    
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Key messages  
 
• Although national policies promote breastfeeding (BF) in the context of HIV and 
universal maternal antiretroviral therapy (ART), recent data are lacking on BF practices 
in South Africa 
• Using data from a prospective cohort of peri-urban breastfeeding mother-infant pairs 
in Cape Town, South Africa, we report inappropriately early cessation of both exclusive 
and all BF, regardless of maternal HIV status 
• We identify lactation problems and maternal employment as major obstacles to optimal 
breastfeeding in our setting 
• Urgent improvements in lactation support are required, and structural interventions at 

















Exclusive breastfeeding (EBF) is considered nutritionally complete and the best form of 
nutrition for infants in the first five to 6 months of their life. (1–9)    Breastfeeding and 
appropriate complementary feeding practices should ideally continue beyond the first,(1) 
through to the second year of a child’s life. (2–10)   
Breastfeeding is beneficial to both infant and mother, both in the long- and short term. (7) It 
is associated with increased intelligence, reduced risk of developing diabetes and overweight 
as well as reduced infectious illness and mortality. (7,11–13)  While benefits are applicable to 
both HIV-uninfected as well as HIV-infected infants and young children, breastmilk-associated 
HIV transmission can occur, especially in the context of mixed feeding. (9) 
For this reason, historically, breastfeeding was avoided by most women living with HIV 
(WLHIV) in an attempt to reduce the risk of vertical transmission. (9,14) However, across sub-
Saharan Africa including South Africa,  breastfeeding avoidance resulted in high levels of 
infectious disease morbidity and deaths among HIV exposed infants. (5,6) In recognition of 
these risks, the World Health Organization (WHO) adopted a pro-breastfeeding policy change 
for resource-limited settings with high infectious burden in 2010. (6)  At this time, 
breastfeeding was re-instated as the HIV infant feeding practice of choice in Prevention of 
Mother to Child Transmission (PMTCT) programmes. (15,16)  Nevertheless, confidence in 
breastfeeding was lost in the era of distributing breastmilk substitutes in the context of HIV 
in South Africa, and was not easily restored despite the WHO policy changes. (15,17) 
Breastfeeding rates remained suboptimal in South Africa among both WLHIV and HIV-
negative mothers. (18)   
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Strong evidence of the protective effects of maternal antiretroviral therapy (ART) to reduce 
breastmilk-associated HIV transmission (19–21) led to the introduction of “universal” (no 
restrictions) ART for all pregnant and breastfeeding women (“Option B/B+”), promoted since 
2013. Subsequently, South Africa introduced the “Option B/B+” PMTCT policy. (19,20,22) 
Of note, the potential health benefits associated with Option B+ cannot be realized without 
improvements in breastfeeding rates. (23)  However, data on breastfeeding practices since 
the pro-breastfeeding policy change, in the context of Option B/B+, is limited. Studies 
conducted in the transition period from exclusive formula to EBF policies indicated 
suboptimal feeding practices in the Western Cape (24), however improvements were seen 
nationally in early EBF despite low EBF prevalence. (25)  Hence, more research is necessary to 
identify barriers and facilitators of optimal breastfeeding practices in the context of both ART 
and pro-breastfeeding policies. 
The aim of this study is therefore to describe, explore and compare breastfeeding practices 
and identify predictors of early breastfeeding cessation among WLHIV and HIV-negative 
women in Gugulethu, in the first three years after the introduction of Option B+ policies in 
the Western Cape.  We attempted to highlight focus areas that should be addressed to restore 
confidence in breastfeeding and promote better breastfeeding practices among both WLHIV 









We conducted a secondary analysis of data from two linked, prospective cohort studies 
conducted in parallel at the Gugulethu Midwife Obstetric Unit (MOU), a primary care centre 
in Cape Town, South Africa.  Study participants comprised WLHIV who initiated universal ART 
in pregnancy, and their HIV-exposed, uninfected (HEU) infants from the “Maternal and Child 
Health Anti-Retroviral Therapy” (MCH-ART) study; and HIV-negative mothers and their HIV-
unexposed, uninfected infants (HU) of the “HIV-Unexposed Uninfected” (HU2) mother and 
infant study. (26)  While MCH-ART was conducted from 2013 to 2016, HU2 ran from 2014 to 
2017; both studies used the same staff, measurement tools and were based at the same 
research site. (26) Both studies screened and enrolled women at their first antenatal visit, 
with follow-up through delivery to the first postnatal visit. (26) At the first postpartum study 
visit (within 7 days postpartum, window to 28 days for MCH-ART and 6 weeks for HU2), 
breastfeeding mother-infant pairs were screened and enrolled for further postnatal follow-
up. (26) 
Postnatal follow-up visits for breastfeeding mother-infant pairs were scheduled at 6 weeks 
and three, 6, 9 and 12 months postpartum.  The current analysis focuses on the longitudinal 
breastfeeding practices of mother-infant pairs participating in the postnatal phase. As 
determinants of breastfeeding duration among HIV-infected children may be different to 
those for HIV-uninfected children of WLHIV, we excluded the breastfeeding data of infants 
who became HIV-infected from this analysis. Details of mother to child transmission in these 






Trained study field workers administered structured questionnaires at all study visits. These 
included infant feeding intentions and practices questionnaires, validated in previous 
Prevention of Mother to Child Transmission PMTCT studies. (3) Questionnaires were identical 
in both parent studies, except for HIV-related questions.  Additionally, selected data on 
maternal demographic and health information, such as for e.g. pregnancy planning, as well as 
psychosocial and behavioural measures including depression (Edinburgh Postnatal 
Depression Scale, EPDS)(28), psychological distress (Kessler-10 scale)(29), intimate partner 
violence (WHO Violence against women questionnaire)(30) and alcohol use (Alcohol Use 




Research was based at a research unit adjacent to the Gugulethu MOU on the premises of 
the Gugulethu Primary Healthcare Centre.  The unit is certified as baby-friendly. (32) The 
facility is located in Gugulethu, a low income, peri urban township in the Klipfontein district 
of Cape Town, which provides services to a population of roughly 350 000 people, (33) with 
estimated 30% antenatal HIV seroprevalence (16). Since 2013, universal maternal 
antiretroviral therapy (ART without CD4 cell count restrictions) has been provided by the 







Sample size calculations were based on primary outcomes for the parent studies, published 
elsewhere. (26,34). For the purposes of this secondary analysis and in accordance with 
international epidemiological recommendations, a post-hoc power calculation was not 
indicated. (35,36) Throughout, results are presented with 95% confidence intervals (CI) to 
demonstrate achieved precision. Data were analysed using Stata 14.0 (Statacorp, College 
Station, Texas USA); p-values are two-sided. 
Breastfeeding practices were described using three WHO core indicators for breastfeeding. 
(2,3,10)  These included 1) prevalence of early initiation of breastfeeding (EIBF, put to the 
breast within the first hour of life) (2,3,10); 2) prevalence of infants exclusively breastfed (EBF, 
feeding infants no other food or drink other than breastmilk, except for medicines, vitamins 
and minerals) for the first 6 months of life (2,3,10); and 3) prevalence of any breastfeeding at 
12 months of age. (2,3,10) The primary outcomes for this analysis were duration of a) 
exclusive and b) any breastfeeding.  We estimated duration of EBF and BF and timing of 
introduction of complementary food using both 24-hour recall at each visit and maternal 
report of feeding practices since the last visit. We allocated the EBF and BF date as the date 
of the last study visit at which the mother reported these; similarly, complementary food 
introduction was allocated as the first date the mother reported this.  The exact date of 
breastfeeding cessation and complementary food introduction was not determinable.  The 
primary comparison for this analysis was between WLHIV and HIV-negative women, using Cox 
proportional hazards regression analysis to generate crude (HR) and adjusted (aHR) hazard 
ratios. We further described age of introduction to complementary feeding, and maternal 
reports of lactation problems and reasons for cessation of breastfeeding, in exploratory 
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analysis. We assessed factors associated with breastfeeding practices among WLHIV and HIV-
negative women separately, with a focus on the consequences of lactation problems.   
Potential third variables were identified a priori using a directed acyclic graph based on the 
available literature regarding breastfeeding in the context of HIV (7) (Supplementary Figure1). 
Potential confounders of the maternal HIV status – breastfeeding relationships included 




Both MCH-ART and HU2 were approved by the Human Research Ethics Committee of the 













Between 5 June 2013 and 5 April 2016, a total of 1087 mother-infant pairs were screened at 
the first postnatal study visit (MCH-ART, n=587; HU2, n=500), of whom 203 were excluded 
from further follow-up (study flow and reasons for exclusion in supplementary figure 2).  
Postnatal follow-up was concluded for all participants by 28 March 2017, excluding 12 infants 
who acquired HIV during follow-up. The combined cohort of 872 mothers and their HIV-
negative infants [n=461 HIV-exposed uninfected children (HEU) from MCH-ART and n=411 
HIV-unexposed children (HU) from HU2] contributed a total of 925 person-years of follow-up. 
The median (interquartile range, IQR) follow-up time was 12.1 (IQR 12.0: 17.7) months, with 
MCH-ART mother-infant pairs completing longer median follow-up time than HU2 (17.0 IQR 
11.9; 18.0 vs 12.1 IQR 12.0; 12.3 months, p<0.0001). 
 
Maternal and infant characteristics 
Overall, 31% (270/872) of pregnancies were planned; fewer WLHIV had planned their 
pregnancy compared to HIV-negative women (28% [131/461] vs 34% [139/411], p=0.09)  and 
most women were neither married nor cohabitating (57% [499/872]), with a median maternal 
age of 28 (IQR 24; 32) years. The latter two characteristics did not vary significantly by 
maternal HIV status (Table 1). WLHIV reported substantially worse socio-economic 
environments than HIV-negative women, with a lower proportion living in homes with all 
amenities, including running water, electricity and a toilet. (27 
% [125/461] vs 40% 164/411], p<0.0001). WLHIV also had a lower prevalence of secondary 
education attainment compared to HIV-negative women (25% [114/461] vs 45% 184/411], 
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p<0.0001) and employment (39% [182/461] vs 47% [194/411], p=0.02). At postnatal 
enrolment visit, WLHIV (vs HIV-negative) reported a greater prevalence of psychosocial and 
behavioural difficulties including postnatal depression (10% [46/461] vs 7% [29/411], p=0.12), 
intimate partner violence (22% [101/461] vs 8% [32/411], p<0.0001) and risky drinking (25% 
[117/461] vs 7% [30/411], p<0.0001).  The classification of psychosocial and behavioural 
difficulties is defined in the footnote of Table 1. 
The median birthweight of infants born across both cohorts was 3180 (IQR 2820; 3460) grams. 
HEU infants were born with a slightly lower birthweight (vs HU infants) with a median of 3130 
(IQR 2760; 3400) vs 3220 (IQR 2850; 3510) grams, p=0.01.  The median gestation at birth was 
39 (IQR 38; 40) weeks with 11% (94/872) of infants born prematurely (<37 weeks) and 13% 
(113/872) of infants being born small for their gestational age (SGA).  These birth outcomes 
did not vary significantly by maternal HIV status (Table 1). 
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TABLE 1:  Maternal and Infant Characteristics of HIV-exposed (HEU) and HIV-unexposed (HU), breastfed infants 
 Combined Cohort n= 
872 
Women Living with HIV 
and their Infants (n=461, 
53%) 
HIV-Negative Mothers 
and their infants (n=411, 
47%) 
p-value Data missing 
Maternal Characteristics      
Maternal age (years) 28 (24; 32) 28 (24; 32) 28 (23; 32) 0.13 n=0 
Completed secondary and or tertiary 
schooling1 
298 (34%) 114 (25%) 184 (45%) <0.0001 n=0 
Employed2 376 (43%) 182 (39%) 194 (47%) 0.02 n=0 
Married/cohabitating3 373 (43%) 189 (41%) 184 (45%) 0.26 n=0 
Planned pregnancy4 270 (31%) 131 (28%) 139 (34%) 0.09 n=0 
Normal vaginal delivery5 578 (67%) 323 (70%) 255 (62%) 0.01 n=0 
Breast infection/problems at 7 days and 
or 6 weeks6 
143 (16%) 92 (20%) 51 (12%) 0.0003 n=0 
Lives in formal housing with a toilet, 
running water and electricity7 
289 (33%) 125 (27%) 164 (40%) <0.0001 n=0 
Postnatal depression8 75 (9%) 46 (10%) 29 (7%) 0.12 n=0 
Intimate partner violence9 133 (15%) 101 (22%) 32 (8%) <0.0001 n=0 
Risky drinking behaviour10 147 (17%) 117 (25%) 30 (7%) <0.0001 n=2 
Psychological distress11 228 (26%) 27 (6%) 201 (49%) <0.0001 n=2 
Diagnosed HIV-positive during this 
pregnancy12 
- 262 (57%) - - n=0 
Log10 HIV viral load at ART initiation - 3.97 (3.35; 4.54) - - n=0 
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TABLE 1:  Maternal and Infant Characteristics of HIV-exposed (HEU) and HIV-unexposed (HU), breastfed infants 
 Combined Cohort n= 
872 
Women Living with HIV 
and their Infants (n=461, 
53%) 
HIV-Negative Mothers 
and their infants (n=411, 
47%) 
p-value Data missing 
CD4 count at ART initiation (cells/uL) - 354 (249; 527) - - n=12 
Viral suppression at delivery13 - 352 (76%) - - n=0 
Infant and Delivery Characteristics      
Male sex14 424 (49%) 228 (50%) 196 (48%) 0.17 n=3 
Gestational age at birth (weeks) 39 (38; 40) 39 (38; 40) 39 (38; 40) 0.42 n=0 
Birth weight (grams) 3180 (2820; 3460) 3130 (2760; 3400) 3220 (2850; 3510) 0.01 n=0 
SGA15 113 (13%) 67 (15%) 46 (11%) 0.15 n=3 
APGAR <7 @ 5 minutes16 7 (1%) 5 (1%) 2 (1%) 0.32 n=0 
Prematurity17 94 (11%) 56 (12%) 38(9%) 0.17 n=0 






















Duration of hospital stay after birth (days) 0 (0; 3) 0 (0; 2) 0 (0; 3) 0.04 n=0 
Trimester of entry into antenatal care 
First (≤12 weeks) 
Second (>12, <28 weeks) 



















†Results are n (column %) with bivariate comparisons obtaining p-values from the chi-squared test.  Median with interquartile range (IQR) with p-value from Wilcoxon rank sum test for 2 
sample comparisons and Kruskal Wallis test for >2 sample comparisons for non-normally distributed variables.  
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1As compared to having attained less than secondary education. 
2As compared to unemployed 
3As compared to not married / cohabitating 
4As compared to current pregnancy was not planned 
5As compared to a caesarean section 
6As compared to not having had breast infections/ problems at 7 days and 6 weeks 
7As compared to not living in formal housing with a toilet, running water and electricity 
8 Postnatal depression is defined as Edinburgh Postnatal Depression Scale (EPDS) score ≥13, at enrolment visit.  As compared to having an EPDS score of <13, at enrolment visit.(28) 
9 Intimate partner violence defined as physical, sexual or psychological violence as per World Health Organization violence against women questionnaire, at enrolment visit.  As compared to 
not having experienced intimate partner violence, at enrolment visit.(30) 
10 Risky drinking behaviour is defined as Alcohol use disorders identification test (AUDIT-C) score ≥3, at enrolment visit.  As compared to having an AUDIT-C score of <3, at enrolment visit.(31) 
11 Psychological distress is defined as Kessler Psychological Distress Scale (K10) score ≥21.5, at enrolment visit.  As compared to having a K10 score of <21.5, at enrolment visit. (29) 
12Timing of diagnosis during this pregnancy as compared to during a previous pregnancy.  
13Viral suppression defined as a viral load of <50 copies per millilitre (copies/mL) 
14Male sex, as compared to female sex. 
15 SGA refers to Small for Gestational Age defined as weight below the 10th percentile for gestational age.   
16As compared to having an APGAR score of ≥ 7 at 5 minutes. 
17Prematurity refers to Gestational Age of less than 37 weeks.  As compared to term delivery. 











Summary of infant feeding practices overall and by maternal HIV status 
Breastfeeding practices differed by maternal HIV status (Table 2). While an overall 91% 
(788/867) of infants received EIBF, this was only 87% (400/459) among HEU vs 95% (388/408) 
among HU infants (p<0.0001). Overall, 34% (156/461) of infants were exclusively breastfed 
through age 6 months, with significantly higher proportions among HEU (54%, 120/221) than 
HU infants (15%, 36/240), p<0.0001.  Furthermore, while a total of 44% (317/719) of infants 
were breastfed at 12 months of age, only 39% (142/366) of HEU infants were still being 
breastfed, while half (50%, 175/353) of the HU infants were still breastfed (p=0.01). 
The duration of any breastfeeding across both cohorts was a median of 6.0 months (IQR 1.5; 
12), with HEU infants breastfed for shorter compared to HU infants, with a median of 3.9 months 
(IQR 1.4; 12.0)  vs 9.0 months (IQR 3.0; 12.05)  (p<0.0001).  Among infants who were ever 
exclusively breastfed, HEU infants were exclusively breastfed for markedly longer with a median 
duration of 1.5 months (IQR 0.3; 5.3), as compared to HU infants with a median of 1.4 months 
(IQR 0.2; 3.0), p=0.01.  The median duration of exclusive breastfeeding among both cohorts was 
1.4 (IQR 0.1; 3.0) months. 
Overall, 62% (448/722) of infants were introduced to complementary feeding at the WHO 
recommended age of 6 months; this was no different between HEU and HU infants.  However, 
while substantially fewer HEU compared to HU infants were introduced to complementary foods 
at younger than 4 months (6% [22/376] vs 14% [48/346], p<0.0001) and between 4 and 6 
months (7% [27/376] vs 17% [60/346], p<0.0001), more HEU vs HU infants were introduced to 



















Early initiation of 
breastfeeding 
788/867 (91%) 400/459 (87%) 388/408 (95%) <0.0001 
Ever Exclusively 
breastfed 
754/872 (86%) 421/461 (91%) 333/411 (81%) 
<0.0001 
Exclusively breastfed at  
7 days  753/118 (86%) 420/460 (91%) 333/411 (81%) <0.0001 
6 weeks  494/740 (67%) 295/373 (79%) 199/367(54%) <0.0001 
3 months  353/577 (61%) 205/255 (80%) 148/322 (46%) <0.0001 
6 months  156/461 (34%) 120/221 (54%) 36/240 (15%) <0.0001 
Breastfed at 
7 days  872/872 (100%) 461/461 (100%) 411/411 (100%) - 
6 weeks  740/822 (90%) 373/434 (86%) 367/388 (95%) <0.0001 
3 months  577/734 (79%) 255/366 (70%) 322/368 (88%) <0.0001 
6 months  461/747 (62%) 221/401 (55%) 240/346 (69%) <0.0001 
9 months 382/712 (54%) 174/382 (46%) 208/330 (63%) <0.0001 
12 months  317/719 (44%) 142/366 (39%) 175/353 (50%) 0.01 
Duration of any 
breastfeeding (months) 
6.0 (1.5; 12.0) 3.9 (1.4; 12.0) 9.0 (3.0; 12.05) <0.0001 
Duration of Exclusive 
breastfeeding (months) 
1.4 (0.2; 3.1) 1.5 (0.3; 5.3) 1.4 (0.2; 3.0) 0.01 
Age of introduction to 
complementary food1 
<4 months 


























†Results are n (column %) with bivariate comparisons obtaining p-values from the chi-squared test.  Median with interquartile range (IQR) 
with p-value from Wilcoxon rank sum test for 2 sample comparisons and Kruskal Wallis test for >2 sample comparisons for non-normally 
distributed variables.  







Summary of lactation problems 
WLHIV compared with HIV-negative women were substantially more likely to report having 
experienced breast infections or problems in the first 6 weeks postpartum, with 20% (92/461) 
of WLHIV and only 12% (51/411) of HIV-negative women having reported breast related 
issues (p=0.003) (Table 1).  The most common complaints across cohorts were cracked nipples 
and breast engorgement (Figure 1A and 1B).  A breakdown of reported breast and lactation 
problems in the first 6 weeks postpartum is included as Supplementary Table 1. 
Figure 1A:  Specific lactation issues reported by women living with HIV and HIV-negative 




























Figure 1A:   
HIV-Negative Women:  Engorgement 1% (6/411); Cracked Nipples 5% (20/411); Other 0.5% (2/411) 
Women living with HIV:  Engorgement 3% (15/461); Cracked Nipples 5% (21/461); Abscess 0.2% (1/461); Infection 0.2% 
(1/461); Other 1% (3/461) 
Total Cohort:  Engorgement 2% (21/872); Cracked Nipples 5% (41/872); Abscess 0.1% (1/872); Infection 0.1% (1/872); Other 
1% (5/872) 




Figure 1B:  Specific lactation issues reported by women living with HIV and HIV-negative 


























Figure 1B:   
HIV-Negative Women:  Engorgement 1% (3/411); Cracked Nipples 2% (9/411); Abscess 0.5% (2/411); Infection 
0.2% (1/411) Other 0.2% (1/411) 
Women living with HIV:  Engorgement 3% (12/461); Cracked Nipples 6% (29/461); Abscess 2% (7/461); Infection 1% (5/461); 
Other 2% (8/461) 
Total Cohort:  Engorgement 2% (15/872); Cracked Nipples 4% (38/872); Abscess 1% (9/872); Infection 1% (6/872); Other 1% 
(9/872) 






Reasons for breastfeeding cessation 
Across the cohort, 13% (111/824) women reported breastfeeding cessation at the second 
postpartum visit at 6 weeks. (Supplementary Table 2).  The main reasons for breastfeeding 
cessation at this visit were lactation problems (20%, 22/111), followed by perceived 
insufficient breastmilk supply (16%, 18/111) and work-related commitments (11%, 12/111).  
Notably, while 27% (22/78) of WLHIV indicated lactation problems to be the reason for BF 
cessation at the 6-week postpartum visit, 0% (0/33) of HIV-negative women reported this to 
be the reason for BF cessation at this visit.  
Overall, most women reported breastfeeding cessation since the last visit at the infants’ 
three- (18%, 135/737) and six-month visit (18%, 134/749).  From the three-months’ through 
to the 12-months’ visit, work related commitments were the main reason women indicated 
for breastfeeding cessation (24%, 131/552).  
Relative hazard of EBF cessation comparing WLHIV to HIV-negative women  
In the overall cohort, maternal HIV-status (positive vs negative) was significantly associated 
with a reduced relative hazard of EBF cessation (HR 0.78, 95% CI 0.67 – 0.90; Table 3a).  
Potential confounders of the maternal HIV status-EBF cessation relationship such as higher 
maternal age and low birth weight (birthweight <2500g) were significantly associated with a 
reduced relative hazard of EBF cessation. Conversely, any lactation problems in the first 6 
weeks postpartum (defined as reported at either of 7 days’ or 6 weeks’ study visit) and 
maternal psychological distress were significantly associated with increased relative hazard 
of EBF cessation across cohorts (Table 3a).  After adjusting for employment, maternal age and 
confounders such as living in housing with all amenities, as well as risky drinking behaviour, 
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maternal HIV status was persistently associated with a reduced hazard of EBF cessation (aHR: 
0.76 CI: 0.65 – 0.89).   
Relative hazard of all BF cessation comparing WLHIV to HIV-negative women  
In the overall cohort, maternal HIV-status was associated with an increased relative hazard of 
all BF cessation (HR 1.87 CI 1.56 – 2.24, Table 3b).  In addition, lactation problems in the first 
6 weeks postpartum, employment and risky drinking behaviour were significantly associated 
with increased relative hazard of all BF cessation across cohorts.  Low birth weight, EIBF and 
late entry into antenatal care (defined as entering antenatal care after 28 weeks’ gestation), 
were associated with a markedly reduced relative hazard of BF cessation (Table 3b).  After 
adjusting for employment, maternal age and potential confounders including living in a house 
with all amenities, as well as risky drinking behaviour, maternal HIV-status was persistently 
associated with an increased hazard of BF cessation (aHR: 1.85 CI:1.53 – 2.24).  Therefore, 
while the time to EBF cessation was longer in WLHIV, time to all BF cessation was longer in 




TABLE 3. Factors associated with cessation of (a) exclusive breastfeeding or (b) all breastfeeding among women living with HIV compared to HIV-
negative women: crude and adjusted hazard ratios from Cox proportional hazards regression   




















Maternal characteristics         
HIV-Positive1 0.78 (0.67 – 0.90) 0.001 0.76 (0.65 – 0.89) 0.001 1.87 (1.56 – 2.24) <0.0001 1.85 (1.53 – 2.24) <0.0001 
Breast infection/problems at 7 days and 
or 6 weeks2  
1.46 (1.17 – 1.81) 0.001 - - 1.98 (1.56 – 2.51) <0.0001 - - 
Employed3 1.11 (0.96 – 1.29) 0.16 1.10 (0.95 – 1.23) 0.20 1.28 (1.07 – 1.53) 0.01 1.40 (1.17 – 1.67) <0.0001 
Maternal age (years) 0.99 (0.97 – 1.00) 0.01 0.99 (0.97 – 0.99) 0.02 0.99 (0.98 – 1.01) 0.98 0.99 (0.98 – 1.00) 0.27 
Completed secondary and or tertiary 
schooling4 
1.05 (0.91 – 1.23) 0.49 - - 0.97 (0.80 – 1.16) 0.71 - - 
Lives in formal housing with a toilet, 
running water and electricity5 
1.11 (0.95 – 1.29) 0.18 1.07 (0.91– 1.25) 0.42 0.94 (0.78 – 1.14) 0.54 0.99 (0.82 – 1.20) 0.92 
Postnatal depression6 1.27 (1.00 – 1.62) 0.05 - - 0.92 (0.65 – 1.30) 0.65 - - 
Intimate partner violence7 0.97 (0.79 – 1.19) 0.78 - - 1.22 (0.96 – 1.54) 0.11 - -- 
Risky drinking behaviour8 1.08 (0.90 – 1.30) 0.40 1.20 (0.91 – 1.25) 0.07 1.58 (1.28 – 1.96) <0.0001 1.35 (1.09 – 1.69) 0.01 
Psychological distress9 1.31 (1.11 – 1.54) 0.001 - - 0.83 (0.68 – 1.03) 0.09 -  
Infant and Delivery Characteristics         
Gestational age at birth         
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TABLE 3. Factors associated with cessation of (a) exclusive breastfeeding or (b) all breastfeeding among women living with HIV compared to HIV-
negative women: crude and adjusted hazard ratios from Cox proportional hazards regression   





















≥34 Weeks, <37 Weeks 
<34 Weeks 
1.00 
0.81 (0.63 – 1.04) 









1.04 (0.76 – 1.41) 



































Birth weight (kilograms) 1.12 (1.00 – 1.26) 0.05 - - 0.86 (0.74 – 0.99) 0.04   
SGA10 0.88 (0.73 – 1.06) 0.19 - - 1.08 (0.84 – 1.40) 0.53 - - 
APGAR <7 @5min11 1.32 (0.66 – 2.60) 0.43 - - 1.23 (0.48 – 2.65) 0.78 - - 
Put to breast within 1 hour of birth12 1.04 (0.82 – 1.32) 0.74 - - 0.67 (0.52 – 0.87) 0.01 - - 






1.03 (0.88 – 1.19) 















0.93 (0.77 – 1.12) 













Entry into antenatal care 
Early (<28 Weeks) 
Late (≥28 Weeks) 
 
1.00 
























TABLE 3. Factors associated with cessation of (a) exclusive breastfeeding or (b) all breastfeeding among women living with HIV compared to HIV-
negative women: crude and adjusted hazard ratios from Cox proportional hazards regression   




















Male Sex14 0.89 (0.77 – 1.03) 0.12 - - 0.93 (0.78 – 1.11) 0.42 - - 
†Analysis based on a) 754 observations; 1726.02 months total analysis time and b) 870 observations; 6132.60 months total analysis time  
‡Exclusive Breastfeeding analysis was restricted to infants who were ever breastfed. 
1 Reference category:  HIV-negative 
2 Reference category:  not having had breast infections/ problems at 7 days and 6 weeks 
3 Reference category:  being unemployed 
4 Reference category:   having attained less than secondary education 
5 Reference category: not living in formal housing with a toilet, running water and electricity 
6 Postnatal depression is defined as Edinburgh Postnatal Depression Scale (EPDS) score ≥13, at enrolment visit. (28)  
   Reference category: having an EPDS score of <13, at enrolment visit 
7 Intimate partner violence defined as physical, sexual or psychological violence as per World Health Organization violence against women questionnaire, at enrolment visit.   
   Reference category: not having experienced intimate partner violence, at enrolment visit.(30) 
8 Risky drinking behaviour is defined as Alcohol use disorders identification test (AUDIT-C) score ≥3, at enrolment visit. (31) 
   Reference category:  having an AUDIT-C score of <3, at enrolment visit 
9 Psychological distress is defined as Kessler Psychological Distress Scale (K10) score ≥21.5, at enrolment visit.(29) 
   Reference category: having a K10 score of <21.5, at enrolment visit   
10 SGA refers to Small for Gestational Age defined as weight below the 10th percentile for gestational age.  
   Reference category:  Weight above the 10th percentile for gestational age 
11 Reference category:  APGAR ≥ 7 @ 5 minutes 
12 Reference category:  Not having been put to the breast within 1 hour after birth 
13 BBA refers to Born before arrival, defined as infants born at home or on route to a delivery centre, without the presence of a skilled birth attendant 
14 Reference category:  female sex 
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Predictors of EBF and all BF cessation among WLHIV  
In analysis restricted to WLHIV (Table 4), lactation problems were associated with an 
increased relative hazard of both EBF and BF cessation ([HR 1.48 CI 1.13 – 1.96] and [HR 2.31 
CI 1.73 – 3.08]).  While older maternal age was associated with a decreased relative hazard of 
EBF cessation, postnatal depression and psychological distress were associated with an 
increased relative hazard of EBF cessation.  After adjusting for maternal age, postnatal 
depression, EIBF and low APGAR scores at birth, lactation problems remained significantly 
associated with EBF cessation in WLHIV (aHR: 1.54 CI: 1.16 – 2.03).   
Older maternal age and late entry into antenatal care (≥28 Weeks) were associated with a 
reduced relative hazard of BF cessation among WLHIV, while employment and risky drinking 
behaviour were associated with an increased relative hazard of BF cessation.  After adjusting 
for maternal age, employment, postnatal depression and EIBF, lactation problems persisted 
to be associated with increased risk of BF cessation (aHR: 2.45 CI: 1.85 – 3.24). The adjusted 
hazard for employment (Table 4) indicated a 41% increased hazard of BF cessation among 
mothers who were employed compared to those unemployed after considering lactation 
problems and other potential confounders (aHR: 1.41 CI: 1.11 – 1.78).   
Predictors of EBF and all BF cessation among HIV-negative women  
In analyses restricted to HIV-negative women (Supplementary Table 3), lactation problems 
remained predictive of EBF cessation (aHR: 1.62 CI: 1.15 – 2.27) but the association with any 
BF was attenuated among HIV-negative women (aHR: 1.44 CI: 0.91 – 2.27).  The most marked 
predictors of all BF cessation were employment (HR: 1.35 CI: 1.01 – 1.79), psychological 
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distress, (HR 1.37 CI 1.03 – 1.83) and low birth weight (HR 0.72 CI 0.57 – 0.92). Results were 




TABLE 4. Factors associated with cessation of (a) exclusive and (b) all breastfeeding among women living with HIV: crude and adjusted hazard ratios 
from Cox proportional hazards regression analysis 









p-value Crude Hazard Ratio 
(95% Confidence 
Interval) 





Maternal characteristics         
Breast infection/problems at 7 days and 
or 6 weeks1  
1.48 (1.13 – 1.96) 0.05 1.54 (1.16 – 2.03) 0.01 2.31 (1.73 – 3.08) <0.0001 2.45 (1.85 – 3.24) <0.0001 
Employed2 1.05 (0.86 – 1.28) 0.64 - - 1.36 (1.08 – 1.71) 0.01 1.41 (1.11 – 1.78) 0.01 
Maternal age (years) 0.98 (0.97 – 1.00) 0.02 0.98 (0.97 – 1.00) 0.03 0.98 (0.97 – 0.99) 0.01 0.99 (0.97 – 1.01) 0.51 
Completed secondary and or tertiary 
schooling3 
0.93 (0.74 – 1.18) 0.57 - - 1.10 (0.85 – 1.42) 0.46 - - 
Lives in formal housing with a toilet, 
running water and electricity4 
1.08 (0.87 – 1.34) 0.48 - - 0.97 (0.75 – 1.25) 0.81 - - 
Postnatal depression5 1.40 (1.01 – 1.92) 0.04 1.46 (1.11 – 1.93) 0.01 0.97 (0.64 – 1.46) 0.87 0.93 (0.59 – 1.46) 0.75 
Intimate partner violence6 1.01 (0.79 – 1.27) 0.97 - - 0.94 (0.71 – 1.24) 0.64 - - 
Risky drinking behaviour7 1.15 (0.94 – 1.42) 0.18 - - 1.30 (1.02 – 1.68) 0.04 - - 
Psychological distress8 1.30 (1.02 – 1.67) 0.04 - - 0.92 (0.55 – 1.51) 0.73 - - 
Infant and Delivery Characteristics       - - 




















TABLE 4. Factors associated with cessation of (a) exclusive and (b) all breastfeeding among women living with HIV: crude and adjusted hazard ratios 
from Cox proportional hazards regression analysis 









p-value Crude Hazard Ratio 
(95% Confidence 
Interval) 





≥34 Weeks, <37 Weeks 
<34 Weeks 
0.97 (0.71 – 1.33) 







0.95 (0.63 – 1.43) 


































Birth weight (kilograms) 1.01 (0.87 – 1.17) 0.95 - - 1.10 (0.89 – 1.34) 0.37 - - 
SGA9 0.95 (0.75 – 1.21) 0.70 - - 0.93 (0.67 – 1.29) 0.67 - - 
APGAR <7 @5min10 1.30 (0.56 – 3.00) 0.55 0.83 (0.32 – 2.14) 0.70 1.36 (0.76 – 2.44) 0.30 - - 
Put to breast within 1 hour of birth11 0.95 (0.74 – 1.22) 0.70 0.96 (0.73 – 1.26) 0.76 0.71 (0.54– 0.95) 0.02 0.70 (0.52 – 0.94) 0.02 






1.08 (0.88 – 1.32) 















0.95 (0.76 – 1.21) 













Entry into antenatal care 
Early (<28 Weeks) 
Late (≥28 Weeks) 
 
1.00 






















Male Sex13 0.89 (0.73 – 1.08) 0.23 - - 0.82 (0.65 – 1.02) 0.08 - - 
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†Analysis based on a) 421 observations; 1090.26 months total analysis time and b) 461 observations; 2987.99 months total analysis time  
‡Exclusive Breastfeeding analysis was restricted to infants who were ever breastfed. 
1 Reference category:   having attained less than secondary education 
2 Reference category:  not having had breast infections/ problems at 7 days and 6 weeks 
3 Reference category:  being unemployed 
4 Reference category: not living in formal housing with a toilet, running water and electricity 
5 Postnatal depression is defined as Edinburgh Postnatal Depression Scale (EPDS) score ≥13, at enrolment visit. (28)  
   Reference category: having an EPDS score of <13, at enrolment visit 
6 Intimate partner violence defined as physical, sexual or psychological violence as per World Health Organization violence against women questionnaire, at enrolment visit.   
   Reference category: not having experienced intimate partner violence, at enrolment visit.(30) 
7 Risky drinking behaviour is defined as Alcohol use disorders identification test (AUDIT-C) score ≥3, at enrolment visit. (31) 
   Reference category:  having an AUDIT-C score of <3, at enrolment visit 
8 Psychological distress is defined as Kessler Psychological Distress Scale (K10) score ≥21.5, at enrolment visit.(29) 
   Reference category: having a K10 score of <21.5, at enrolment visit   
9 SGA refers to Small for Gestational Age defined as weight below the 10th percentile for gestational age.  
   Reference category:  Weight above the 10th percentile for gestational age 
10 Reference category:  APGAR ≥ 7 @ 5 minutes 
11 Reference category:  Not having been put to the breast within 1 hour after birth 
12 BBA refers to Born before arrival, defined as infants born at home or on route to a delivery centre, without the presence of a skilled birth attendant 





In this observational cohort study, we observed suboptimal breastfeeding practices among 
WLHIV and HIV-negative mothers, despite pro-breastfeeding policy changes and universal 
ART use among the former.  Our study findings are similar to those of another study which 
reported suboptimal breastfeeding practices between 2012 and 2013 in the Western Cape, 
during the transition period from exclusive formula feeding to exclusive breastfeeding policies 
in the context of HIV and prior to the widespread availability of universal ART. (24)  That is, 
our data suggests that guideline changes alone did not translate into improved breastfeeding 
practices. 
We found that while EIBF, was less common in HEU infants, considerably more HEU compared 
to HU infants were exclusively breastfed for 6 months.  However, the duration of any 
breastfeeding was shorter in HEU- compared to HU infants. Results regarding EBF from other 
South African studies show quite the opposite, in that EBF rates were lower among WLHIV at 
14 weeks postpartum (37) and at  all times up until 6 months postpartum. (38)  These 
differences may be explained by the fact that the first study was conducted in a rural setting, 
prior to the pro-breastfeeding policy change, while the latter study, though conducted in an 
urban setting, post the policy change, had a small sample size. 
We found that maternal HIV status was a substantial threat to optimal BF duration.  A study 
conducted in northwest Ethiopia found similar results in that the duration of all BF was shorter 
by 3.4 times in WLHIV compared to HIV-negative mothers. (39) We found psychosocial-
behavioural adversities to be particularly common among WLHIV, with postnatal depression 
associated with early EBF cessation among WLHIV.  These findings are corroborated by a 
Nigerian study (40), and highlight the importance of psychosocial-behavioural problem 
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screening and referral structures to be put in place in the antenatal care setting, particularly 
for WLHIV. 
Despite all study participants attending antenatal care at a “Baby-Friendly” hospital, lactation 
problems were commonly reported in our study, and strongly predictive of both EBF and BF 
cessation. Lactation problems, usually indicative of incorrect positioning and latching (41)  are 
known to predict suboptimal breastfeeding (18,42) and are largely preventable through 
adequate breastfeeding support. (41) In the context of maternal HIV, concerns should extend 
to increased risks of vertical HIV transmission, especially related to bleeding and 
inflammation. (43) Clearly, pro-breastfeeding guideline changes are inadequate without also 
improving breastfeeding support for WLHIV. In order to both prevent mother-to-child 
transmission (MTCT) and optimize HEU child health, an urgent upscaling of the BF support 
services is imperative in our context. Studies in South Africa and Kenya have reported the key 
roles health care workers (HCW) play in providing breastfeeding support (44–46), while 
simultaneously highlighting issues around the training of and advice given by HCW. (44–49)  
This highlights the need for building HCW knowledge and competency in providing feeding 
advice and support. However, it is increasingly evident that BF support by HCW is inadequate, 
and broader-based community outreach projects have shown great promise in providing the 
additional support women require in the vulnerable first few weeks after delivery. (50–52)  
An additional threat to optimal BF duration that emerged in our analysis is maternal 
employment, an issue evident for both WLHIV and HIV-negative women.  This finding aligns 
with data from Nigeria, Kenya, rural KwaZulu-Natal and urban Botswana, where employment 
was observed to be associated with suboptimal EBF, regardless of HIV status (39,40) and 
strongly associated with early weaning (37), particularly among WLHIV. (53)  Reasons for this 
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are likely complex and  combine issues such as informal employment, no job protection,  lack 
or duration of maternity leave and being the main breadwinner of a household. (54)  This 
highlights the need for workplace and structural interventions around issues such as paid 
maternity leave, job protection and availability of lactation rooms to enable mothers to 
continue breastfeeding while retaining their employment.  It also highlights the role that HCW 
could play in providing tailor-made lactation advice for working mothers. More interventions 
should focus on supporting mothers who return to work. (55) 
 Our data demonstrate that despite advances in policies towards promoting breastfeeding, 
real-life and “on the ground” implementation remains suboptimal. Mothers are faced with a 
multitude of challenges, including difficulties with lactation, socio-behavioural struggles and 
the need to return to work, all of which affect BF practices negatively. (13)   
Since both lactation problems as well as employment remained strong predictors of EBF and 
BF cessation in this analysis, it is crucial that interventions address these, to improve EIBF, EBF 
and BF for reduced child morbidity and mortality. (7) Health systems need to ensure regular 
contact with postpartum women and HCW – extending to community supporters - should be 
skilled to provide tailor-made breastfeeding advice, lactation support (48), and screening for 
psychosocial behavioural issues, within the context of appropriate referral structures.  
HCW based interventions that have shown promise include regular hospital based follow-ups 
and breastfeeding support as seen in northern Ethiopia,  demonstrating improvements in 
breastfeeding practices from the first week to six months post-partum. (56) 
Another low-cost intervention that could be considered, would be the training of peer 
counsellors.  Despite South African sites reporting mixed results for promoting EBF among 
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WLHIV, (50,51) this intervention has improved EBF duration and initiation in low and middle 
income countries. (50) 
Interventions combining community and interpersonal communication activities at scale, 
similar  to the Alive and Thrive initiative in rural, low-income Burkina Faso (52) may have the 
potential to improve breastfeeding outcomes and increase breastfeeding related knowledge. 
(52)  However, the financial implications of such interventions may limit their 
implementation. (55)   
The findings of this study should be interpreted in the light of several study limitations and 
strengths. This study is an observational study, thereby at risk for bias and confounding.  
Although we attempted to address these in both the study design and analysis, some issues 
to internal validity may have persisted, including recall bias.  Our wide and intensive measures 
of maternal psycho-social wellbeing provide unique insight into early postpartum 
breastfeeding obstacles, but data are lacking on the precise details of HCW lactation support 
and the exact dates of EBF and BF cessation. Our findings might not be generalizable to other 
peri-urban settings in South Africa, nor to rural areas where breastfeeding practices may 
differ substantially. Nonetheless, we provide robust data that illustrate a convincing picture 
of ongoing suboptimal breastfeeding practices that require urgent attention in our setting. 
Future research should focus on a combination of interventions that best support 
breastfeeding mothers.  These should include, but not be limited to, upskilling HCW to provide 
regular and up to date breastfeeding support, as well as work-place interventions on various 
levels, from the individual company to policy level, to give the structural support needed by 





We found the matter of suboptimal breastfeeding practices in the South African context to 
be complex and multifaceted, even more so in the light of HIV.  Since policies supportive of 
breastfeeding have been implemented in South Africa, it is crucial that HCW who provide 
feeding support and counselling receive the necessary training and knowledge to provide pro-
breastfeeding advice and intensified, hands-on lactation support. Furthermore, referral 
channels for psychosocial and behavioural adversities should be in place and HCW should be 
familiar with these, especially in the context of WLHIV. It is important to strengthen continuity 
of care for mother-infant pairs throughout pregnancy and postnatal journey. This will help to 
address any feeding related issues early.  Additionally, workplace interventions need to be 
put in place to provide structural breastfeeding support.  Ultimately, this will help improve 
overall breastfeeding practices and subsequently will be beneficial to maternal and child 
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-   MCH-ART study HREC approval     
-   HU2 study HREC approval   
-   MCH-ART & HU2 inclusion/exclusion criteria        
-   Infant feeding intentions/practices questionnaire   
-   HU2 Maternal Demographics & Medical History Questionnaire 
-   MCH-ART Demographics & Medical History Questionnaire 
-   Directed Acyclic Graph (DAG) 
-   MCH-ART Phase 2 informed consent form       
-   MCH-ART Phase 3 informed consent form       
-   HU2 Informed consent form, Antenatal Phase 
-   HU2 Informed consent form, Postnatal Phase 
-   Edinburgh Postnatal Depression Scale (EPDS)   
-   Kessler-10 (K-10) 
-   Trauma / Abuse Assessment (WHO VAW Questionnaire) 
-   Alcohol Use Disorders Identification Test (AUDIT)   



























Phase 1:  Inclusion criteria: antenatal  
For both groups, inclusion criteria will include: 
• First antenatal booking for index pregnancy 
• Maternal age of 18 years or older 
• Confirmed pregnancy 
• Able to provide informed consent for research 
• HIV-testing conducted at least once during current pregnancy, with results 
available 
a. Specific to HEU group: 
• Booking HIV test positive in index pregnancy 
• Initiating ART during index pregnancy 
b. Specific for HU group: 
• Booking HIV test negative in index pregnancy 
Phase 2 & 3:  Inclusion criteria: postnatal 
For both groups, inclusion criteria will include: 
• Had breastfed at any point during the first week post-delivery  
• Willingness to return for postnatal study visits 
• Able to provide informed consent for research 
c. Specific for HEU group 
• Had been enrolled and seen for at least one antenatal MCH-ART study visit 
• Willingness to allow minimally invasive infant blood sampling at 12 months 
d. Specific for HU group 
• Had been enrolled and seen for at least one antenatal HU2 study visit 
Exclusion criteria: antenatal and postnatal 
Individuals meeting any of the following exclusion criteria at any point in either study will 
be excluded:  
• Not currently pregnant (antenatal phase) or loss of pregnancy/neonate (postnatal 
phase) at the time of eligibility determination  
• Intention to relocate out of Cape Town permanently during the study period  
• Any medical, psychiatric or social condition which in the opinion of the investigators 
would affect the ability to consent and/or participate in the study (all phases), 
e. Specific for HEU group 
67 
Infants who test HIV-positive at any point during postnatal follow-up will not be 
excluded from the study but their outcome measures will be analysed separately. 
f. Specific for HU group
Women who seroconvert and subsequently test HIV-positive after enrolment will
continue study follow-up where possible; the maternal and infant health outcomes of
this group will be analysed separately.
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- Directed Acyclic Graph (DAG) -
93 
Directed Acyclic Graph 
Exposure: 
Maternal HIV Status 
Confounders 
• Socio-economic Status

















































- Edinburgh Postnatal Depression Scale (EPDS)  -
HIV-Unexposed cohort: Edinburgh Postnatal Depression Scale, 1st Antenatal & Postnatal visits at 6 weeks & 12 months           PID: A/P - __ __ __ __  
Xhosa-English Version 2.0, 18th June 2014 
Page 1 of 1            Initials of counsellor: ________ 
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EPDS  
Visit Date: __ __/__ __ __/__ __ __ __ Visit number 
Please circle appropriate visit 
1st Antenatal (booking) visit 6 weeks postnatal visit 12 months postnatal visit 
Sifuna ukwasi ukuba ubuziva njani kwiveki ephelileyo. Sicela ukhethe iimpendulo ezikufutshane nendlela ozive ngayo kwi veki edlulileyo, hayi nje indle oziva 
ngayo namhlanje. 
We would like to know how you have been feeling in the past week. Please choose the answer that comes closest to how you have felt in the past week, not just how you feel today. Please read all the 
options for each statement. 
 0 1 2 3 
EPDS -1 
Ndibenako ukuhleka nokubona icala lezinto 
ezinga lunganga. 
I have been able to laugh and see the funny side of 
things 
Njengokuba ndihlala ndisenza 
As much as I always could 
Hayi Kangako 
Not quite so much now. 
Ngokuqinisekileyo akukho 
kangako ngoku 
Definitely not so much now. 
Hayi azange 
Not at all. 
EPDS -2 
 
Izinto ndizijonge ndinolonwabo 
I have looked forward with enjoyment to things 
Njengokuba bendihlala ndisenza 
As much as I ever did. 
Kancinci kunokuba bendihlala 
ndisenza 
A little less than I used to. 
Kancinci kakhulu kunokuba 
bendisenza 
Much less than I used to. 
Kungqabile ukuba kubenjalo. 
Hardly at all. 
EPDS -3 
Bendizigxeka xa izinto zingandihambeli 
kakuhle ngaphandle kwesizathu. 
I have blamed myself unnecessarily when things went 
wrong 
Ewe, ixesha elininzi 
Yes, most of the time. 
Ewe, ngamanye amaxesha 
Yes, some of the time. 
Hayi kangako 




Bendinxunguphele ndinexhala ngaphandle 
kwesizathu 
I have been anxious or worried for no good reason 
Hayi konke konke 
No, not at all. 
Kungqabile ukuba kubenjalo 
Hardly ever. 
Ewe, ngamanye amaxesha 
Yes, sometimes. 
Ewe kakhulu 
Yes, very much. 
EPDS -5 
Ndizive ndisoyika ndinexhala ngaphandle 
kwesizathu 
I have felt scared or panicky for no very good reason 
Ewe kakhulu 
Yes, quite a lot. 
Ewe, ngamanye amaxesha 
Yes, sometimes. 
Hayi kangako 
No, not much. 
Hayi konke konke 
No, not at all 
EPDS -6 Izinto bezindongamela 
Things have been getting on top of me 
Ewe, ixesha elininzi 
bedingakwazi ukuphumelela tu 
Yes, most of the times I haven't 
been managing at all. 
Ewe, ngamanye amaxesha 
bendingakwazi ukuphumelela 
njengesiqhelo 
Yes, sometimes I haven't been 
managing as well as usual. 
Hayi, ixesha elininzi 
bendiphumelela kakuhle kakhulu 
No, most of the time I have 
managed quite well. 
Hayi, benoliphumelela 
njengesiqhelo 
No, I have been managing as 
well as ever. 
EPDS -7 
Bendingonwabanga ndifumane ubunzima 
xa kufuneka ndilele 
I have been so unhappy that I have had difficulty 
sleeping 
Ewe, ixesha elininzi 
Yes, most of the time. 
Ewe, ngamanye amaxesha 
Yes, sometimes. 
Hayi kangako 
Not very much. 
Hayi konke konke 
No, not at all. 
EPDS -8 Ndiziva ndilusizi okanye ndingxunguphele 
I have felt sad or miserable 
Ewe, ixesha elininzi 
Yes, most of the time. 
Ewe, ngamanye amaxesha 
Yes, sometimes. 
Hayi kangako 
Not very much. 
Hayi konke konke 
No, not at all. 
EPDS -9 Bendingonwabanga ndisoloko ndilila 
I have been so unhappy that I have been crying 
Ewe, ixesha elininzi 
Yes, most of the time. 
Ewe, ngamanye amaxesha 
Yes, sometimes. 
Hayi kangako 
Not very much. 
Hayi konke konke 
No, not at all. 
EPDS -10 Ingcinga yokuzenzakalisa ithe yandifikela 
The thought of harming myself has occurred to me 
Ewe kakhulu 
Yes, quite a lot 
Ngamanye amaxesha 
Sometimes 




Date completed: __ __ /__ __ __ / __ __ __ __              Signed counsellor completing CRF: ____________________ 
Date of QC: __ __ /__ __ __ / __ __ __ __                    Signed measurement nurse: _________________ 
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APPENDIX M 
- Kessler-10 (K-10) -
HIV-unexposed cohort: K-10, Antenatal visit 1; Postnatal visits 6 weeks and 12 months      PID: A/P - __ __ __ __ - __ __ 
Xhosa-English Version 1.0, 15th April 2014 
Page 1 of 1        Initials of counsellor: ________ 
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KESSLER-10 
Visit Date: __ __/__ __ __/__ __ __ __ 
Visit number 
Please circle appropriate visit 
1st Antenatal visit (booking) 6 weeks postnatal 12 months postnatal 
Le mibuzo ilandelayo ilishumi ikubuza ukuba ubuziva njani na kule nyanga idlulileyo. Ngombuzo ngamnye yakha isangqa phantsi phantsi kwalo mpendulo ichaza 
ngokupheleleyo ubungakanani bexesha obuvakalelwa ngalo ngolo hlobo. 
The following ten questions ask about how you have been feeling in past month.  
Kule nyanga iphelileyo, oku kukuthi, ukususela [xela inyanga enye edlulileyo] ukuyo kutsho izolo, ikuba kukangaphi uziva: 






















All of the 
time 
K10 -1 
Udiniwe ngaphandle kwesizathu? 
During the past month, about how often did you feel tired out for no good reason? 
1 2 3 4 5 
K10 -2 
Uphakuphaku? 
During the past month, about how often did you feel nervous? 
1 2 3 4 5 
K10 -3 
Uphakuphaku kangangokuba kungekho nto inokukuthomalalisa? 
During the past month, about how often did you feel so nervous that nothing could calm 
you down? 
1 2 3 4 5 
K10 -4 
Uphelelwa ngamathemba? 
During the past month, about how often did you feel hopeless? 
1 2 3 4 5 
K10 -5 
Ungazinzanga okanye ugungqa? 
During the past month, about how often did you feel restless or fidgety? 
1 2 3 4 5 
K10 -6 
Ungazinzanga de ugugqagungqe xa uhleli? 
During the past month, about how often did you feel so restless you could not sit still? 
1 2 3 4 5 
K10 -7 
Ulusizana udakumbile? 
During the past month, about how often did you feel depressed? 
1 2 3 4 5 
K10 -8 
Yonke into ibiyimigudu? 
During the past month, about how often did you feel that everything was an effort? 
1 2 3 4 5 
K10 -9 
Udakumbile kangangokuba kungekho nanye into engakonwabisayo? 
During the past month, about how often did you feel so sad that nothing could cheer you 
up? 
1 2 3 4 5 
K10 -10 
Ungena xabiso? 
During the past month, about how often did you feel worthless? 
1 2 3 4 5 
Date completed: __ __ /__ __ __ / __ __ __ __ Signed counsellor completing CRF: ____________________ 
Date of QC: __ __ /__ __ __ / __ __ __ __  Signed measurement nurse: ________________
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- Trauma / Abuse Assessment (WHO VAW Questionnaire) -
HU-cohort: Trauma/ Abuse assessment, 1st Antenatal & Postnatal 12 month visits    PID: A/P - __ __ __ __ - __ __ 
Xhosa-English Version 2.0, 18th June 2014 
Page 1 of 1 Initials of counsellor: ________ 
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WHO VAW QUESTIONNAIRE 
Visit Date:   
     __ __/__ __ __/__ __ 
__ __ 
Visit number: 
Please indicate the 
visit 
1st Antenatal visit 
Postnatal visit 12 
months 
Siza kubuza imibuzo embalwa malunga nokuhlukunyezwa kwako liqabane lako. 
We are going to ask you a few questions relating to partner violence. 
Kwezi nyanga zi-12 zidlulileyo ukhe wafunyanwanzezi zilandelayo 








Iqabane lakho likhe lakuthuka okanye wasiva ungalunganga? 
Has your partner insulted you or made you feel bad about yourself? 
1 0 
2. 
Likhe lakwenza wasifumanisa ukuba usithobile isidima sakho phambi 
kwabanye abantu? 
Has he belittled or humiliated you in front of other people? 
1 0 
3. 
Likhe laoyikisa lakuphatha kakubi ngabom 
Has he done things to scare or intimidate you on purpose? 
1 0 
4. 
Likhe lakugrogrisa ngokonzakalisa okanye umntu omnakekelayo? 









Likhe lakuqhwaba ngempama okanye wakugibisela ngento 
enokwenzakalisa? 
Has he slapped you or thrown something at you that could hurt you? 
1 0 
6. 
Likhe lakutyhala okanye lakunyola? 
Has he pushed or shoved you? 
1 0 
7. 
Likhe lakubetha ngenqindi okanyengento enokonzakalisa? 
Has he hit you with a fist or with something else that could hurt you? 
1 0 
8. 
Likhe likukhabe,likurhuqe okanye likubethe? 
Has he kicked you, dragged you or beaten you up? 
1 0 
9. 
Likhe likukrwitshe okanye likutshise ngabom? 
Has he choked or burnt you on purpose? 
1 0 
10. 
Likhe likugrogrise okanye lisebenzise umpu,imela okanye nasiphi 
isixhobo kuwe? 
Has he threatened to use or actually used a gun, knife or other weapon against you? 
1 0 







Likhe likunyanzele ngokwabelana ngocantsi wena ungafuni? 
Has he physically forced you to have sexual intercourse when you didn’t want to? 
1 0 
12. 
Wakhe wabelana naye ngocantsi ungafuni kuba uloyika umazi 
angenza ntoni? 
Did you ever have sexual intercourse when you didn’t want because you were afraid of 
what he might do? 
1 0 
13. 
Likhe likunyanzele ngokwebelana ngocantsi ngendlela ofumanisa 
ukuba ukuthathela phantsi okanye uyakwenyelisa? 
Has he forced you to do something sexual that you found degrading or humiliating? 
1 0 
Date completed: __ __ /__ __ __ / __ __ __ __   Signed counsellor completing CRF: ____________ 
Date of QC: __ __ /__ __ __ / __ __ __ __    Signed measurement nurse: _________________ 
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- Alcohol Use Disorders Identification Test (AUDIT)  -
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AUDIT Please mark relevant visit number: 
1st Antenatal 
visit (booking) 
12 month visit Visit Date: 
 __ __/__ __ __/__ __ __ __ 
Ngoku sizakubuza imibuzo ngokusebenzisa kwakho utywala. Ncede urhangqe impendulo engqamene nawe: 
We are now going to ask you some questions about your use of alcohol. Please circle the relevant answer for each question bellow: 
0 1 2 3 4 
AUDIT -1 Ubusela kangakanani utywala? 























4 times or more 
per week 
AUDIT -2 
Zingaphi iglasi zesiselo esinxilisayo 
oziselayo ngemini? 
How many standard drinks containing alcohol do you 
have on a typical day when drinking? 
1 okanye 2 
1 or 2 
3 okanye 4 
3 or 4 
5 okanye 6 
5 or 6 
7 ukuya 9 





Kukangaphi usela iglasi ezintandathu 
nangaphezulu ngexesha? 
How many times do you have six standard drinks or 














Daily or almost daily
AUDIT -4 
Kunyaka ophelileyo kukangaphi, 
ufumanisa ukuba awukwazi ukuyeka 
ukusela xa sele uqalili? 
During the past year, how often have you found that 















Daily or almost daily
AUDIT -5 
Kulo nyaka uphelileyo kukangaphi 
ungakwazi ukwenza into ubumele 
ukuyenza ngenxa yokuba ubusela? 
During the past year, how often have you failed to do 



















Kulo nyaka uphelileyo kukangaphi ufuna 
ukusela utywala ekuseni kuba  ufuna 
ukuqala usuku lwakho kakuhle? 
During the past year, how often have you needed a 















Daily or almost daily 
AUDIT -7 
Kulonyaka uphelileyo kukangaphi 
uzifumanise unesazela okanye uzisola 
emva kokuba usele? 
During the past year, how often have you had a feeling 














Daily or almost daily 
AUDIT -8 
Kulo nyaka uphelileyo ukhe wazilibala 
izinto ebezenzekile ngezolo ngenxa 
yokuba ubusele? 
During the past year, have you been unable to 
remember what happened the night before because 














Daily or almost daily 
AUDIT -9 
Ukhe wonzakala okanye omnye umntu 
wonzakala ngenxa yokuba ubusele? 
















Sikhona isizalwana sakho, okanye 
isihlobo,ugqira okanye umntu  
osebenzela ezempilo  obekhathazekile 
ngendlela osela ngayo waza wakucebisa  
ukuba  uthobe isantya? 
Has a relative or friend, doctor or other health worker 
















Date completed: __ __ /__ __ __ / __ __ __ __             Signed counsellor completing CRF: ____________________ 
Date of QC: __ __ /__ __ __ / __ __ __ __                    Signed measurement nurse: _________________ 
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DATA MANAGEMENT PLAN 
Institution: University of Cape Town 
1. PROJECT NAME 
Early infant breastfeeding practises and predictors of breastfeeding cessation in HIV-
uninfected and HIV-infected mothers on anti-retroviral treatment: a prospective cohort 
study 
 
2. LEAD PRINCIPAL INVESTIGATOR(S)/GRANT HOLDER 
Dr Stanzi le Roux, Supervisor of Helene C Theunissen  
 
3. DATA COLLECTION/GENERATION 
This study involves secondary data analysis only.  
Data was obtained through Clinical record forms (CRFs), and questions were administered by 
trained interviewers in private rooms.  CRFs were translated from English into isiXhosa and 
subsequently back-translated by isiXhosa speaking staff members, with validation 
certification.  
For the purposes of this study, data derived from the “Infant feeding intentions/practices” 
questionnaire (Appendix D) will be used to evaluate breastfeeding practices.  This 
questionnaire was administered in both parent cohorts during post-natal follow up visits at 
approximately <7 days, 6 weeks, 3,6,9 and 12 months.  Additionally, selected data derived 
from the “Maternal Demographics & Medical History Questionnaire” will be used, as well as 
the Edinburgh Postnatal Depression Scale (EPDS) (Appendix L), the Kessler-10 (Appendix M), 
the Trauma/Abuse Assessment (Appendix N) and the Alcohol Use Disorders Identification Test 
(AUDIT) (Appendix O).  The HU2 questionnaire (Appendix E) was an appropriately shortened 
version (so as not to enquire about HIV/ART related information) of that of MCH-ART. 
(Appendix F). 
 
4. DATA STORAGE 
As per study protocols, all participant data was kept anonymous with no personal identifiers 
attached to participant files and with only systematically assigned identification 
numbers.  Database files are stored on password protected external hard drives which in 
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SUPPLEMENTARY TABLE 1:  Specific lactation issues reported by women living with HIV and HIV-negative women at approximately 7 days 
and 6 weeks postpartum 
Visit Lactation issue Combined Cohort n= 872 Women Living with HIV and their 
Infants 
HIV-Negative Mothers and their 
infants 
7 Days postpartum Engorgement 21/872 (2%) 15/461(3%) 6/411 (1%) 
Cracked Nipples 41/872 (5%) 21/461 (5%) 20/411 (5%) 
Abscesses 1/872 (0.1%) 1/461 (0.2%) 0/411 (0%) 
Infection 1/872 (0.1%) 1/461 (0.2%) 0/411 (0%) 
Operation 0/872 (0%) 0/461 (0%) 0/411 (0%) 
Trauma 0/872 (0%) 0/461 (0%) 0/411 (0%) 
Other problems1 5/872 (1%) 3/461 (1%) 2/411 (0.5%) 
6 Weeks postpartum Engorgement 15/872 (2%) 12/461 (3%) 3/411 (1%) 
Cracked Nipples 38/872 (4%) 29/461 (6%) 9/411 (2%) 
Abscesses 9/872 (1%) 7/461 (2%) 2/411 (0.5%) 
Infection 6/872 (1%) 5/461 (1%) 1/411 (0.2%) 
Operation 0/872 (0%) 0/461 (0%) 0/411 (0%) 
Trauma 0/872 (0%) 0/461 (0%) 0/411 (0%) 
Other problems2 9/872 (1%) 8/461 (2%) 1/411 (0.2%) 
Results are n(column %) 
1 Other lactation problems women indicated included itchiness, painful nipples, pain when breastfeeding and painful breasts. 
2Other lactation problems women indicated included bleeding nipples, empty breasts or not enough breastmilk. 
Supplementary Table 1 provides a breakdown of reported lactation and breast problems in the first 6 weeks postpartum.  The most common 
problem reported by 5% (41/872) of all women, was cracked nipples at the 7-day postpartum visit, this was no different among WLHIV as 
compared to HIV-negative women (5%, 21/461 vs 5%, 20/411).  This was followed by engorgement, with 3% (15/461) of WLHIV as compared 
to 1% (6/411) of HIV-negative women reporting this problem at the 7-day postpartum visit. 
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Cracked nipples and engorgement continued to be the main lactation related problems reported at the 6-weeks postpartum visit.  While 6% 
(29/461) of WLHIV reported having cracked nipples, only 2% (9/411) HIV-negative women reported this problem.  Similarly, while 3% (12/461) 
of WLHIV reported breast engorgement, only 1% (3/411) reported this problem at the 6 weeks postpartum visit. 
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SUPPLEMENTARY TABLE 2: Maternal reasons for cessation of breastfeeding, by study visit:  overall, and stratified by maternal HIV status 
Visit Combined Cohort Women Living with HIV and their Infants HIV-Negative women and their infants 
6 Weeks Number who attended this visit  824/872 (94%) 435/461 (94%) 389/411 (95%) 
Number (%) who reported breastfeeding 
cessation since previous visit 
111/824 (13%) 78/435 (18%) 33/389 (8%) 
Reasons given for Breastfeeding cessation 
No reason given 23/111 (21%) 6/78 (8%) 17/33 (52%) 
Work 12/111 (11%) 10/78 (13%) 2/33 (6%) 
Education 2/111 (2%) 1/78 (1%) 1/33 (3%) 
Non-lactational illness 11/111 (10%) 8/78 (10%) 3/33 (9%) 
Lactation problems 22/111 (20%) 22/78 (27%) 0/33 (0%) 
Poor growth 1/111 (1%) 0/78 (0%) 1/33 (3%) 
Inconsolable crying 6/111 (5%) 3/78 (4%) 3/33 (9%) 
Insufficient breastmilk supply 18/111 (16%) 13/78 (17%) 5/33 (15%) 
Fear of HIV transmission 3/111 (2%) 3/78 (4%) 0/33 (0%) 
External advice/pressure 2/111 (2%) 2/78 (3%) 0/33 (0%) 
Other1 11/111 (10%) 10/78 (13%) 1/33 (3%) 
3 Months 
Number who attended this visit  737/872 (85%) 369/461 (80%) 368 (90%) 
Number (%) who reported breastfeeding 
cessation since previous visit 
135/ 737 (18%) 98/369 (27%) 37/368 (10%) 
Cumulative number of women who have 
stopped breastfeeding 
246/872 (28%) 176/461 (38%) 70/411 (17%) 
Reasons given for Breastfeeding cessation 
No reason given 47/135 (36%) 31/98 (33%) 16/37 (43%) 
Work 31/135 (23%) 22/98 (22%) 9/37 (24%) 
Education 2/135 (1%) 1/98 (1%) 1/37 (3%) 
Non-lactational illness 3/135 (2%) 3/98 (3%) 0/37 (0%) 
Lactation problems 11/135 (8%) 8/98 (8%) 3/37 (8%) 
Poor growth 3/135 (2%) 3/98 (3%) 0/37 (0%) 
Inconsolable crying 4/135 (3%) 2/98 (2%) 2/37 (5%) 
Insufficient breastmilk supply 15/135 (11%) 10/98 (10%) 5/37 (14%) 
Fear of HIV transmission 1/135 (1%) 1/98 (1%) 0/37 (0%) 
External advice/pressure 0/135 (0%) 0/98 (0%) 0/37 (0%) 
Other1 18/135 (13%) 17/98 (17%) 1/37 (3%) 
6 Months 
Number who attended this visit  749/872 (86%) 403/461 (87%) 346/411 (84%) 
Number (%) who reported breastfeeding 
cessation since previous visit 
134/749 (18%) 56/403 (14%) 78/346 (22%) 
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Cumulative number of women who have 
stopped breastfeeding 
380/872 (44%) 232/461 (50%) 148/411 (36%) 
Reasons given for Breastfeeding cessation 
No reason given 25/134 (19%) 5/56 (9%) 20/78 (26%) 
Work 46/134 (34%) 17/56 (29%) 29/78 (37%) 
Education 5/134 (4%) 2/56 (4%) 3/78 (4%) 
Non-lactational illness 3/134 (2%) 2/56 (4%) 1/78 (1%) 
Lactation problems 5/134 (4%) 3/56 (5%) 2/78 (3%) 
Poor growth 0/134 (0%) 0/56 (0%) 0 /78 (0%) 
Inconsolable crying 3/134 (2%) 2 /56 (4%) 1 /78 (1%) 
Insufficient breastmilk supply 12/134 (9%) 5/56 (9%) 7 /78 (9%) 
Fear of HIV transmission 2/134 (1%) 2/56 (4%) 0/78 (0%) 
External advice/pressure 0/134 (0%) 0 /56 (0%) 0 /78 (0%) 
Other1 33/134 (25%) 18/56 (32%) 15 /78 (19%) 
9 Months 
Number who attended this visit  714/872 (82%) 384/461 (83%) 330/411 (80%) 
Number (%) who reported breastfeeding 
cessation since previous visit 
89/714 (12%) 49/384 (13%) 40/330 (12%) 
Cumulative number of women who have 
stopped breastfeeding 
469/872 (54%) 281/461 (61%) 188/411 (46%) 
Reasons given for Breastfeeding cessation 
No reason given 14/89 (17%) 2/49 (4%) 12/40 (30%) 
Work 28/89 (31%) 21/49 (43%) 7/40 (17%) 
Education 5/89 (6%) 3 /49 (6%) 2/40 (5%) 
Non-lactational illness 1/89 (1%) 0 /49 (0%) 1 /40 (3%) 
Lactation problems 6/89 (7%) 0/49 (0%) 6/40 (15%) 
Poor growth 1 /89 (1%) 1/49 (2%) 0/40 (0%) 
Inconsolable crying 2/89 (2%) 2/49 (4%) 0 /40 (0%) 
Insufficient breastmilk supply 3/89 (3%) 2/49 (4%) 1 /40 (3%) 
Fear of HIV transmission 1/89 (1%) 1/49 (2%) 0/40 (0%) 
External advice/pressure 0/89 (0%) 0 /49 (0%) 0/40 (0%) 
Other1 28/89 (31%) 17/49 (35%) 11 /40 (27%) 
12 Months 
Number who attended this visit  741/872 (85%) 388/461 (84%) 353/411 (86%) 
Number (%) who reported breastfeeding 
cessation since previous visit 
83/741 (11%) 35/388 (9%) 48/353 (14%) 
Cumulative number of women who have 
stopped breastfeeding 
552/872 (63%) 316/461 (69%) 236/411 (57%) 
Reasons given for Breastfeeding cessation 
 
136 
Results are n(column %)  
1  “Other” reasons women gave included but are not limited to maternal depression, the child rejecting breastmilk, the child and mother being separated geographically, the child being 
hospitalized, refusing breastmilk and reduced milk production. 
 
Supplementary Table 2 provides a breakdown of all the reasons women reported for breastfeeding cessation.  At the 6-week postpartum visit, 
the most common reason reported for breastfeeding cessation was lactation problems, 20% (22/111).  While 27% (22/78) WLHIV reported 
lactation problems to be the reason for BF cessation, 0% (0/33) of HIV-negative women reported lactation problems to be the reason for BF 
cessation. 
At the 3-month, 6-month, 9-month and 12-month visits, the most common reason stated by all women for breastfeeding cessation, was work, 
with 23% (31/135), 34% (46/134), 31% (28/89) and 17% (14/83). 
 
No reason given 17/83 (20%) 8/35 (23%) 9/48 (19%) 
Work 14/83 (17%) 5/35 (14%) 9 /48 (19%) 
Education 1/83 (1%) 1/35 (3%) 0/48 (0%) 
Non-lactational illness 2/83 (3%) 1 /35 (3%) 1/48 (2%) 
Lactation problems 4/83 (5%) 0/35 (0%) 4 /48 (8%) 
Poor growth 0/83 (0%) 0/35 (0%) 0 /48 (0%) 
Inconsolable crying 1/83 (1%) 0/35 (0%) 1/48 (2%) 
Insufficient breastmilk supply 8/83 (10%) 0 /35 (0%) 8/48 (17%) 
Fear of HIV transmission 1/83 (1%) 1 /35 (3%) 0/48 (0%) 
External advice/pressure 0/83 (0%) 0/35 (0%) 0/48 (0%) 
Other1 35/83 (42%) 19/35 (54%) 16/48 (33%) 
Main reason 
for cessation 
Work commitments 131/552 (24%) 75/316 (24%) 56/236 (24%) 
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SUPPLEMENTARY TABLE 3:  Factors associated with cessation of (a) exclusive and (b) all breastfeeding among HIV-negative women: crude and adjusted 
hazard ratios from Cox proportional hazards regression analysis. 
 (c) Relative hazard for cessation of exclusive breastfeeding‡ (d) Relative hazard for cessation of any breastfeeding  
Crude Hazard Ratio 
(95% Confidence 
Interval) 
p-value Adjusted Hazard Ratio 
(95% Confidence Interval) 
p-value Crude Hazard Ratio 
(95% Confidence 
Interval) 




Maternal characteristics at first antenatal visit         
Breast infection/problems at 7 days and or 6 weeks1  1.63 (1.17 – 2.26) 0.01 1.62 (1.15 – 2.27) 0.01 1.32 (0.86 – 2.02) 0.21 1.44 (0.91 – 2.27) 0.12 
Employed2 1.15 (0.92 – 1.43) 0.21 - - 1.35 (1.01 – 1.79) 0.04 1.37 (1.02 – 1.84) 0.04 
Maternal age (years) 0.99 (0.97 – 1.01) 0.36 0.99 (0.97 – 1.01) 0.42 0.99 (0.97 – 1.01) 0.42 - - 
Completed secondary and or tertiary schooling3 1.08 (0.87 – 1.34) 0.47 - - 1.10 (0.82 – 1.46) 0.53 - - 
Lives in formal housing with a toilet, running water 
and electricity4 
1.06 (0.86 – 1.32) 0.58 - - 1.07 (0.80 – 1.43) 0.67 - - 
Postnatal depression5 1.11 (0.76 – 1.63) 0.60 1.13 (0.80 – 1.61) 0.48 0.67 (0.35 – 1.30) 0.24 - - 
Intimate partner violence6 1.21 (0.81 – 1.82) 0.35 - - 1.38 (0.87 – 2.19) 0.17 - - 
Risky drinking behaviour7 1.36 (0.83 – 2.24) 0.23 - - 1.38 (0.88 – 2.17) 0.16 - - 
Psychological distress8 1.15 (0.92 – 1.42) 0.22 - - 1.37 (1.03 – 1.83) 0.03 1.35 (1.01 – 1.81) 0.04 
Infant and Delivery Characteristics         
Gestational age at birth 
≥37 Weeks 




0.63 (0.42 – 0.95) 







0.66 (0.44 – 0.99) 






1.12 (0.70 – 1.79) 







0.94 (0.56 – 1.67) 
































Birth weight (kilograms) 1.22 (1.02 – 1.46) 0.03 - - 0.72 (0.57 – 0.92) 0.01 0.71 (0.52 – 0.97) 0.03 
SGA9 0.80 (0.58 – 1.10) 0.16 - - 1.20 (0.81 – 1.78) 0.37 - - 
APGAR <7 @5min10 1.67 (1.04 – 2.70) 0.04 1.24 (0.52 – 2.92) 0.62 4.62e-15 (0) 1.00 - - 
Put to breast within 1 hour of birth11 1.12 (0.62 – 2.04) 0.70 1.03 (0.58 – 1.82) 0.92 0.96 (0.57 – 1.64) 0.90 1.23 (0.67 – 2.27) 0.50 






0.93 (0.74 – 1.17) 





























Entry into antenatal care 
Early (<28 Weeks) 
Late (≥28 Weeks) 
 
1.00 






















Male Sex13 0.93 (0.75 – 1.15) 0.50 - - 1.05 (0.79 – 1.40) 0.70 - - 
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†Analysis based on a) 333 observations; 635.76 months total analysis time and b) 411 observations; 3168.62 months total analysis time 
‡Exclusive Breastfeeding analysis was restricted to infants who were ever breastfed. 
1 Reference category:   having attained less than secondary education 
2 Reference category:  not having had breast infections/ problems at 7 days and 6 weeks 
3 Reference category:  being unemployed 
4 Reference category: not living in formal housing with a toilet, running water and electricity 
5 Postnatal depression is defined as Edinburgh Postnatal Depression Scale (EPDS) score ≥13, at enrolment visit. (28)  
   Reference category: having an EPDS score of <13, at enrolment visit 
6 Intimate partner violence defined as physical, sexual or psychological violence as per World Health Organization violence against women questionnaire, at enrolment visit.   
   Reference category: not having experienced intimate partner violence, at enrolment visit.(30) 
7 Risky drinking behaviour is defined as Alcohol use disorders identification test (AUDIT-C) score ≥3, at enrolment visit. (31) 
   Reference category:  having an AUDIT-C score of <3, at enrolment visit 
8 Psychological distress is defined as Kessler Psychological Distress Scale (K10) score ≥21.5, at enrolment visit.(29) 
   Reference category: having a K10 score of <21.5, at enrolment visit   
9 SGA refers to Small for Gestational Age defined as weight below the 10th percentile for gestational age.  
   Reference category:  Weight above the 10th percentile for gestational age 
10 Reference category:  APGAR ≥ 7 @ 5 minutes 
11 Reference category:  Not having been put to the breast within 1 hour after birth 
12 BBA refers to Born before arrival, defined as infants born at home or on route to a delivery centre, without the presence of a skilled birth attendant 
13 Reference category:  female sex 
    
Supplementary Table 3 is indicative of analyses restricted to HIV-negative women.  Lactation problems were predictive of EBF cessation (aHR 
1.62 CI 1.15 – 2.27), however not significantly predictive of BF cessation (aHR 1.44 CI 0.91 – 2.27).  Relative and adjusted predictors of all BF 
cessation included employment (HR 1.35 CI 1.01 – 1.79), psychological distress (HR 1.37 CI 1.03 – 1.83) and low birth weight (HR 0.72 CI 0.57 – 
0.92).
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Maternal psychosocial and 
behavioural factors 


















































203 mother-infant pairs excluded from postnatal follow-up 
116 HIV-positive mother-infant pairs (MCH-ART study) 
78 not breastfeeding 
23 enrolment window missed 
12 unable to continue follow-up (lack of time or interest / relocation)  
3 transferred to other clinics for HIV care (withdrew) 
87 HIV-negative mother-infant pairs (HU2 study) 
14 not breastfeeding 
63 enrolment window missed 
9 unable to continue follow-up (lack of time or interest / relocation) 
1 maternal HIV sero-conversion during pregnancy (withdrew) 
 
1087 mothers-newborn pairs screened at first postnatal visit 
587 HIV-positive mothers (MCH-ART study) 
500 HIV-negative mothers (HU2 study) 
884 mother-infant pairs enrolled for postnatal follow-up 
471 HIV-positive mother-infant pairs (MCH-ART study) 
413 HIV-negative mother-infant pairs (HU2 study) 
12 mother-infant pairs excluded from breastfeeding analyses due to 
postnatal infant HIV acquisition 
10 HIV-positive mother-infant pairs (MCH-ART study)  
2 HIV-negative mother-infant pairs (HU2 study, postnatal maternal 
seroconversion) 
872 mother-infant pairs included in breastfeeding analysis 
461 HIV-exposed uninfected infants (MCH-ART study) 
411 HIV-unexposed uninfected infants (HU2 study) 
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SUPPLEMENTARY FIGURE 3: Kaplan Meier curve for breastfeeding cessation, comparing women living with HIV to HIV-negative women 
SUPPLEMENTARY FIGURE 3A:  Kaplan Meier curve for breastfeeding 
cessation, comparing women living with HIV to HIV-negative women. 
Exclusive breastfeeding cessation. 
SUPPLEMENTARY FIGURE 3B:  Kaplan Meier curve for breastfeeding 
cessation, comparing women living with HIV to HIV-negative women. 
All breastfeeding cessation. 
The Kaplan Meier curve for exclusive breastfeeding cessation displayed in supplementary figure 3A shows that exclusive breastfeeding duration 
was consistently longer among WLHIV as compared to HIV-negative women (p=0.0004).  The Kaplan Meier curve for (all) breastfeeding cessation 
displayed in supplementary figure 3B on the other hand, shows that the duration of all breastfeeding was shorter among WLHIV as compared 
to HIV-negative women. 
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